LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

AJANTPHARM

NSEBSE
Ajanta Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE031B01049· Scrip: 532331
ENहिन्दीગુજરાતીमराठी
३,०९६.१०
0.20 (-0.01%)
7/5/2026, 12:28:25 pm
NSE
३,०९६.१०
०.२०
-०.०१%
BSE
३,०९३.२५
१९२.३५
+०.००%
2,3762,5662,7562,9453,13505-0707-0208-2910-2812-2402-2304-3005-06
२४४ कारोबारी दिन · 1Y अवधि
आज
खुलना३,१००.००
उच्च३,१०९.३०
निम्न३,०५५.००
पिछला बंद३,०९६.३०
मात्रा६३,३४८
मूल्य₹१९.६Cr
L: 3,055.00H: 3,109.30
52 सप्ताह
निम्न२,३२९.९०
उच्च३,२२८.००
८५% 52 सप्ताह की सीमा में
जानकारी
अंकित मूल्य₹२
सूचीबद्ध2000-05-29
ISININE031B01049
SeriesA
BSE स्क्रिप532331

मुख्य संकेतक

1D
+6.85%
1W
+12.34%
1M
+9.92%
3M
+14.69%
6M
+28.23%
मूल्यांकन
P/E (TTM)४३.७७
P/E (Qtr Ann.)४१.६१
P/Sales८.५६
वृद्धि (तिमाही)
PAT+7.58%
EPS+7.70%
लाभप्रदता
TTM EBITDA M.२९.६%

त्रैमासिक वित्तीय

राजस्व
EBITDA
PAT
EPS
0 Cr297 Cr593 Cr890 Cr1187 Cr22-1223-0323-0923-1224-0324-0624-0924-1210.59.515.516.716.118.817.318.6
तिमाहीराजस्वExpensesEBITDAPBTPATEPS
2024-12-311146 Cr869 Cr343 Cr307 Cr233 Cr18.60
2024-09-301187 Cr916 Cr325 Cr290 Cr216 Cr17.27
2024-06-301077 Cr795 Cr343 Cr311 Cr236 Cr18.77
2024-03-311054 Cr812 Cr312 Cr278 Cr203 Cr16.10
2023-12-311105 Cr828 Cr325 Cr291 Cr210 Cr16.68
2023-09-301028 Cr774 Cr310 Cr276 Cr195 Cr15.51
2023-03-31882 Cr767 Cr185 Cr152 Cr122 Cr9.54
2022-12-31972 Cr838 Cr202 Cr168 Cr135 Cr10.50

शेयरधारिता पैटर्न

वर्तमान2026-03-31
66.3%प्रमोटर
प्रमोटर66.3%
FII8.3%
DII18.4%
सार्वजनिक33.8%
सरकार0.0%
प्रमोटर होल्डिंग ट्रेंड
66.3%24-0666.3%24-0966.3%24-1266.3%25-0366.3%25-0966.3%25-1266.3%26-03

कॉर्पोरेट कार्यवाही

एक्स-तारीखप्रकारउद्देश्य
2025-11-10DividendInterim Dividend - Rs 28 Per Share
2024-11-06DividendInterim Dividend - Rs 28 Per Share
2024-05-30OtherBuy Back
2024-02-08DividendInterim Dividend - Rs 26 Per Share
2023-08-04DividendInterim Dividend - Rs 10 Per Share/Special Dividend - Rs 15 Per Share
2023-03-24OtherBuy Back
2022-11-11DividendInterim Dividend - Rs 7 Per Share
2022-06-22BonusBonus- 1:2
2022-01-13BuybackBuyback
2021-11-09Dividend Interim Dividend - Rs 9.50 Per Share
2020-11-12Buyback Buyback
2020-11-12Dividend Interim Dividend - Rs 9.50 Per Share
2020-07-21Other Annual General Meeting
2019-11-15Dividend Interim Dividend - Rs 13 Per Share
2019-07-09Other Annual General Meeting
2019-02-11Other Buy Back
2018-11-09Dividend Interim Dividend - Rs 9 Per Sh
2018-06-26Other Annual General Meeting
2017-06-23Other Annual General Meeting
2017-03-23Dividend Interim Dividend Rs 7/- Per Share (Purpose Revised)

आय विवरण

Ajanta Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor ...
10 Nov 2022NSE1K chars
Read →
Vide our letter dated 27th October 2022, we had intimated about the Earnings Conference Call schedul...
28 Oct 2022NSE3K chars
Read →
Ajanta Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor ...
3 Aug 2022NSE43K chars
Read →
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations ...
14 May 2022NSE1K chars
Read →
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations ...
31 Jan 2022NSE1K chars
Read →
Ajanta Pharma Limited has informed the Exchange about Schedule of meet of Earnings Conference Call
27 Jan 2022NSE2K chars
Read →
Ajanta Pharma Limited has informed the Exchange about Link of Recording of Earnings call
29 Oct 2021NSE1K chars
Read →
Ajanta Pharma Limited has informed the Exchange about revised Schedule meet of Earnings Conference C...
26 Oct 2021NSE3K chars
Read →
Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation
31 Jul 2019NSE8K chars
Read →
Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation
30 Apr 2019NSE13K chars
Read →
Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation
30 Jan 2019NSE11K chars
Read →
Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation for Q3 2018
25 Jan 2018NSE
Read →

मूल्य इतिहास

तारीखखुलनाउच्चनिम्नबंदमात्रा
2026-05-06२,९५८.१०३,११५.००२,९२४.९०३,०९६.३०७.५८L
2026-05-05२,९१०.००२,९२४.२०२,८५५.६०२,८९७.६०८२,८४१
2026-05-04२,८६८.४०२,९३९.००२,८६८.४०२,९००.७०१.५४L
2026-04-30२,७९०.००२,८४३.८०२,७९०.००२,८२२.७०५९,२२१
2026-04-29२,७७४.००२,८२०.००२,७६०.००२,८०४.२०४५,५२३
2026-04-28२,८२२.००२,८२५.००२,७४०.८०२,७५६.००४५,४१३
2026-04-27२,७६५.२०२,८२८.००२,७५४.२०२,८०७.२०६३,७७२
2026-04-24२,८०१.८०२,८१८.००२,७५५.००२,७६५.३०४७,७३६
2026-04-23२,७७०.००२,८२६.९०२,७६०.००२,७८०.८०५०,२५२
2026-04-22२,७८१.५०२,८१५.४०२,७४९.३०२,७७९.२०५१,१४१
2026-04-21२,७८४.००२,८१६.००२,७७६.००२,७९१.२०१.३९L
2026-04-20२,७९०.२०२,८१६.००२,७६८.५०२,७८१.३०७१,७४८
2026-04-17२,८२९.८०२,८६५.९०२,७८२.६०२,७९०.२०१.१५L
2026-04-16२,९२८.७०२,९२८.७०२,८११.००२,८२७.६०८८,०९८
2026-04-15२,९२५.००२,९३४.००२,८८०.००२,८८३.२०८१,६८२
2026-04-13२,७९७.००२,९३०.३०२,७५८.८०२,८९७.३०१.५८L
2026-04-10२,७७०.००२,८३५.००२,७५०.००२,८०६.००५५,६८५
2026-04-09२,७१०.४०२,७६४.६०२,६९९.००२,७५१.००७६,५४२
2026-04-08२,७६६.००२,७८३.६०२,६९६.६०२,७०९.००१.१५L
2026-04-07२,७२९.१०२,७६६.५०२,७००.००२,७११.६०५१,५१६
2026-04-02२,८१६.००२,८१६.८०२,७२२.८०२,७९१.२०५२,९८६
2026-04-01२,८४९.९०२,८८०.००२,७९०.६०२,८१६.८०६४,८७६
2026-03-27२,८७९.९०२,९१९.९०२,७८०.३०२,८०७.९०९०,२४८
2026-03-25२,९१०.००२,९५७.८०२,८६४.६०२,८७९.९०८८,६९७
2026-03-24२,८२१.१०२,८८१.६०२,७७८.९०२,८६३.२०७२,१६७
2026-03-20२,९७३.२०३,०२०.००२,८७२.५०२,९०४.७०१.११L
2026-03-19३,००९.००३,०७१.६०२,९३१.००२,९४३.९०९७,६५५
2026-03-18३,०४९.९०३,११४.१०३,०२९.३०३,०५६.६०१.२७L
2026-03-17२,९८०.७०३,०७१.६०२,९५९.००३,०२०.६०२.३०L
2026-03-16३,०२०.००३,०६१.२०२,९३०.००२,९५४.१०१.८६L

अक्सर पूछे जाने वाले प्रश्न

के बारे में

अजंता फार्मा लिमिटेड, नेशनल स्टॉक एक्सचेंज ऑफ इंडिया (NSE) पर AJANTPHARM प्रतीक के तहत सूचीबद्ध है, एक प्रमुख भारतीय दवा कंपनी है जो जेनेरिक और विशेष दवाओं के विकास, निर्माण और विपणन में विशेषज्ञता रखती है। प्रमुख उत्पादों में हृदय स्वास्थ्य, श्वसन स्थितियों और केंद्रीय तंत्रिका तंत्र विकारों के लिए दवाएं शामिल हैं, जिनमें एंटी-हिस्टामाइन और एंटी-डिप्रेसेंट पर विशेष ध्यान दिया जाता है।

Advertisement
BOARD OF DIRECTORS
Andheri
Executive Director
Anjana Grewal
Independent Director
DEPARTED